Frederiksberg, Denmark

Kenneth W Harlow

This inventor holds 1 USPTO granted patent. Top assignee: Zealand Pharma A/s. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth W Harlow. Retrieved from https://idiyas.com/inventor/kenneth-w-harlow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kenneth W Harlow

Introduction

Kenneth W Harlow is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of peptide conjugates. His work has implications for medical treatments, especially concerning disorders influenced by nociceptin and related opioid-like peptides.

Latest Patents

Kenneth W Harlow holds a patent for "Diuretic peptide conjugates." This patent discloses a variety of peptide conjugates represented by the general formula: R-Z-X-Z'-R. The patent includes methods for making and using these conjugates. Additionally, it provides antibodies that specifically bind to the peptide conjugates. The present invention has a wide spectrum of important applications, including use in the treatment of disorders impacted by nociceptin and related opioid-like peptides. He has 1 patent to his name.

Career Highlights

Harlow is associated with Zealand Pharma A/S, a company that focuses on the development of innovative peptide-based therapeutics. His work at Zealand Pharma has allowed him to contribute to advancements in medical science, particularly in the area of drug development.

Collaborations

Kenneth W Harlow has collaborated with notable colleagues such as Bjarne Due Larsen and Jørgen Søberg Petersen. Their combined expertise has likely enhanced the research and development efforts at Zealand Pharma.

Conclusion

Kenneth W Harlow's innovative work in peptide conjugates showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various disorders significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…